Overview
Francisco Laranjeira practices practicing medicine in Porto, Portugal.
Mr. Laranjeira is highly rated in 2 conditions, according to our data. His clinical expertise encompasses DPAGT1-CDG, SRD5A3-CDG, ALG1-CDG, and RFT1-CDG.
He is actively involved in clinical research, co-authoring 25 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Francisco S. Laranjeira
Is Francisco S. Laranjeira a top-rated expert for DPAGT1-CDG?
MediFind is an objective health platform that identifies experts based on real-world data. Francisco S. Laranjeira is classified as an Advanced expert for DPAGT1-CDG, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Francisco S. Laranjeira participate in research or clinical trials?
Yes. Francisco S. Laranjeira has published 25 articles and abstracts on conditions like DPAGT1-CDG. You can view a list of Francisco S. Laranjeira's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- DPAGT1-CDGMr. Laranjeira isAdvanced. Learn about DPAGT1-CDG.
- SRD5A3-CDGMr. Laranjeira isAdvanced. Learn about SRD5A3-CDG.
- Experienced
- Acute PancreatitisMr. Laranjeira isExperienced. Learn about Acute Pancreatitis.
- ALG1-CDGMr. Laranjeira isExperienced. Learn about ALG1-CDG.
- Apolipoprotein C2 DeficiencyMr. Laranjeira isExperienced. Learn about Apolipoprotein C2 Deficiency.
- BoilsMr. Laranjeira isExperienced. Learn about Boils.
- Cerebellar HypoplasiaMr. Laranjeira isExperienced. Learn about Cerebellar Hypoplasia.
- EsotropiaMr. Laranjeira isExperienced. Learn about Esotropia.
- Fabry DiseaseMr. Laranjeira isExperienced. Learn about Fabry Disease.
- Familial HypertriglyceridemiaMr. Laranjeira isExperienced. Learn about Familial Hypertriglyceridemia.
- Familial Lipoprotein Lipase DeficiencyMr. Laranjeira isExperienced. Learn about Familial Lipoprotein Lipase Deficiency.
- GangliosidosisMr. Laranjeira isExperienced. Learn about Gangliosidosis.
- Hereditary PancreatitisMr. Laranjeira isExperienced. Learn about Hereditary Pancreatitis.
- High CholesterolMr. Laranjeira isExperienced. Learn about High Cholesterol.
- HypotoniaMr. Laranjeira isExperienced. Learn about Hypotonia.
- Infant HyperglycemiaMr. Laranjeira isExperienced. Learn about Infant Hyperglycemia.
- Interstitial NephritisMr. Laranjeira isExperienced. Learn about Interstitial Nephritis.
- Newborn Low Blood SugarMr. Laranjeira isExperienced. Learn about Newborn Low Blood Sugar.
- PGM1-CDGMr. Laranjeira isExperienced. Learn about PGM1-CDG.
- Phenylketonuria (PKU)Mr. Laranjeira isExperienced. Learn about Phenylketonuria (PKU).
- PMM2-Congenital Disorder of GlycosylationMr. Laranjeira isExperienced. Learn about PMM2-Congenital Disorder of Glycosylation.
- PolymicrogyriaMr. Laranjeira isExperienced. Learn about Polymicrogyria.
- PustulesMr. Laranjeira isExperienced. Learn about Pustules.
- RFT1-CDGMr. Laranjeira isExperienced. Learn about RFT1-CDG.
- Spinal Muscular Atrophy Type 2Mr. Laranjeira isExperienced. Learn about Spinal Muscular Atrophy Type 2.
- Spinal Muscular Atrophy Type 3Mr. Laranjeira isExperienced. Learn about Spinal Muscular Atrophy Type 3.
- Tay-Sachs DiseaseMr. Laranjeira isExperienced. Learn about Tay-Sachs Disease.